0001654954-24-005910.txt : 20240510 0001654954-24-005910.hdr.sgml : 20240510 20240510061433 ACCESSION NUMBER: 0001654954-24-005910 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240510 FILED AS OF DATE: 20240510 DATE AS OF CHANGE: 20240510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INDIVIOR PLC CENTRAL INDEX KEY: 0001625297 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37835 FILM NUMBER: 24932756 BUSINESS ADDRESS: STREET 1: 234 BATH ROAD CITY: SLOUGH, BERKSHIRE STATE: X0 ZIP: SL1 4EE BUSINESS PHONE: 804-379-1090 MAIL ADDRESS: STREET 1: 234 BATH ROAD CITY: SLOUGH, BERKSHIRE STATE: X0 ZIP: SL1 4EE 6-K 1 a8890n.htm BOARD COMMITTEE CHANGES a8890n
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
________________________
 
Washington, D.C. 20549
_____________________
 
FORM 6-K
_____________________
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
 
Date: May 10, 2024
Commission File Number: 001-37835
________________________________________
 
Indivior PLC
________________________________________
 
10710 Midlothian Turnpike, Suite 125
North Chesterfield, Virginia 23235
 
(Address of principal executive office)
 
_______________________________
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F
 
Form 20-F ☒ Form 40-F ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
 
 
 
 
 
 
 
 
 
 
EXHIBIT INDEX
 
 
 
 
 
 
 
 
SIGNATURES
 
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
 
 
Indivior PLC
 
Date: May 10, 2024
/s/ Kathryn Hudson
 
Name: Kathryn Hudson
 
Title: Company Secretary
 
 
 
 EX-99 2 indiviorplc.htm EXHIBIT 99.1 indiviorplc
Exhibit 99.1
 
 
Indivior PLC - Board Committee Changes
 
Slough, UK and Richmond, VA, May 10, 2024 - Indivior PLC announces that Dr. David Wheadon, who will join the Board as an Independent Non-Executive Director on June 1, 2024, has been appointed as a member of the Nomination, Remuneration and Science Committees also with effect from June 1, 2024.
 
Furthermore, in order to comply with Nasdaq's listing rule that requires the Nomination Committee be comprised solely of Independent Directors, Jerome Lande has advised the Board that he will step down as a member of the Nomination Committee with effect from May 31, 2024. Mr. Lande is a Representative Director of Scopia Capital Management LP, who are a significant shareholder of the Group.
 
Following these changes, the membership of the Nomination, Remuneration and Science Committees will be as follows:
 
Nomination Committee
Graham Hetherington (Chair)
Peter Bains
Joanna Le Couilliard
Dr. Keith Humphreys
Barbara Ryan
Mark Stejbach
Juliet Thompson
Dr. David Wheadon
 
Remuneration Committee
Joanna Le Couilliard (Chair)
Peter Bains
Graham Hetherington
Barbara Ryan
Dr. David Wheadon
 
Science Committee
Peter Bains (Chair)
Dr. Keith Humphreys
Barbara Ryan
Mark Stejbach
Dr. David Wheadon
 
This announcement is made in accordance with Listing Rule 9.6.11.
 
Kathryn Hudson
Company Secretary
 
 
Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.